Matches in Nanopublications for { ?s ?p "DDI between Voriconazole and Saxagliptin - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of saxagliptin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of saxagliptin if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB06335]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00582_DB06335 label "DDI between Voriconazole and Saxagliptin - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of saxagliptin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of saxagliptin if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB06335]" assertion.